Akram Ahmad
Akram Ahmad publishes mostly in Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Economics and Econometrics, on topics such as Pharmaceutical Practices and Patient Outcomes, Antibiotic Use and Resistance and Pharmaceutical Economics and Policy.
- World rank
- #2,240,848 of 7,710,434 ranked researchers
- Rank in Malaysia
- #8,986 of 41,196
- Works
- 106
- Citations
- 1.7k
- Citations per work
- 16.1
What does Akram Ahmad research?
Akram Ahmad's work is mostly in Medicine (28%), Immunology and Microbiology (9%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5955.5%
- Health Sciences3028.3%
- Medicine3028.3%
- Life Sciences109.0%
- Social Sciences87.2%
- 1Geriatrics and Gerontology10% of their works
- 2Applied Microbiology and Biotechnology9% of their works
- 3Economics and Econometrics7% of their works
- 4Infectious Diseases7% of their works
- 5Epidemiology6% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Antibiotic Use and Resistance
- Pharmaceutical Economics and Policy
- Vaccine Coverage and Hesitancy
- Pharmacovigilance and Adverse Drug Reactions
- Pneumonia and Respiratory Infections
- Pharmaceutical Quality and Counterfeiting
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe Akram Ahmad's research?
The keywords of their largest research topics: Epidemiology, Inappropriate Medication Use, Polypharmacy, Antibiotic Resistance, Antimicrobial Stewardship, Drug Development Costs, Generic Drugs and COVID-19 Vaccine.
- Quality of Life
- Counterfeit Drugs
- Community-Acquired Pneumonia
- Adverse Drug Reactions
- COVID-19 Vaccine
- Drug Development Costs
- Antibiotic Resistance
- Inappropriate Medication Use
- Epidemiology
- Polypharmacy
- Antimicrobial Stewardship
- Generic Drugs
- Vaccine Hesitancy
- Pharmacovigilance
- Cost-effectiveness Analysis
- Pneumococcal Conjugate Vaccine
- Substandard Medicines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Epidemiology322 topics
- Inappropriate Medication Use281 topic
- Polypharmacy281 topic
- Antibiotic Resistance261 topic
- Antimicrobial Stewardship261 topic
- Drug Development Costs111 topic
- Generic Drugs111 topic
- COVID-19 Vaccine101 topic
- Vaccine Hesitancy101 topic
- Adverse Drug Reactions71 topic
- Pharmacovigilance71 topic
- Community-Acquired Pneumonia61 topic
- Cost-effectiveness Analysis61 topic
- Counterfeit Drugs61 topic
- Pneumococcal Conjugate Vaccine61 topic
- Quality of Life61 topic
- Substandard Medicines61 topic
Where does Akram Ahmad work?
Akram Ahmad's main affiliation in the publication record is UCSI University, Malaysia.
How many publications and citations does Akram Ahmad have?
OpenAlex counts 106 works and 1,710 citations for Akram Ahmad, an h-index of 22, ranking #2,240,848 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Akram Ahmad. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.